BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6189335)

  • 1. Effect of betamethasone valerate on the normal human facial skin flora.
    Daltrey DC; Cunliffe WJ
    Acta Derm Venereol; 1983; 63(2):160-2. PubMed ID: 6189335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid-betamethasone combination in infected eczema: an open, randomized comparison with gentamicin-betamethasone combination.
    Strategos J
    Pharmatherapeutica; 1986; 4(9):601-6. PubMed ID: 3763654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of eczematous dermatitis with amcinonide or betamethasone valerate. A double-blind comparative study.
    Rosenberg EW
    Cutis; 1979 Dec; 24(6):642-5. PubMed ID: 391500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis.
    Weiss SC; Nguyen J; Chon S; Kimball AB
    J Drugs Dermatol; 2005; 4(3):339-45. PubMed ID: 15898290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effect of tacrolimus and betamethasone valerate on the passive sustainable hydration of the stratum corneum in atopic dermatitis.
    Xhauflaire-Uhoda E; Thirion L; Piérard-Franchimont C; Piérard GE
    Dermatology; 2007; 214(4):328-32. PubMed ID: 17460405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue.
    Kristensen JK; Wadskov S; Henriksen O
    Acta Derm Venereol; 1978; 58(2):145-8. PubMed ID: 76394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diprosone (betamethasone dipropionate) cream 0.05%. A review and interim report of a comparative multi-centre study versus betamethasone valerate 0.1%.
    Rhodes EL; Scott LV
    Br J Clin Pract; 1983 Apr; 37(4):130-2. PubMed ID: 6349670
    [No Abstract]   [Full Text] [Related]  

  • 12. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 13. Locoid vs betnovate lotion in the treatment of seborrhoeic and atopic dermatitis of the scalp.
    Turnbull BC
    N Z Med J; 1982 Oct; 95(718):738-40. PubMed ID: 6216427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial.
    Wolf-Jürgensen P
    Curr Med Res Opin; 1979; 5(10):779-84. PubMed ID: 373992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.
    Kucharekova M; Hornix M; Ashikaga T; T'kint S; de Jongh GJ; Schalkwijk J; van de Kerkhof PC; van der Valk PG
    Arch Dermatol Res; 2003 Apr; 295(1):29-32. PubMed ID: 12709818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of facial skin-resident microbiota in Japanese acne patients.
    Numata S; Akamatsu H; Akaza N; Yagami A; Nakata S; Matsunaga K
    Dermatology; 2014; 228(1):86-92. PubMed ID: 24356463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative double-blind study of a 0.1% hydrocortisone-17-butyrate cream (Locoid) and a 0.1% betamethasone-17-valerate cream (Betnovate) in patients with noninfected eczema].
    von Fischer F
    Ther Umsch; 1984 Jun; 41(6):429-32. PubMed ID: 6379975
    [No Abstract]   [Full Text] [Related]  

  • 19. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp.
    Akaza N; Akamatsu H; Numata S; Yamada S; Yagami A; Nakata S; Matsunaga K
    J Dermatol; 2016 Aug; 43(8):906-11. PubMed ID: 26705192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.